Research - Health Care - Harvard Business School

2019
Article

Hospital Adoption of API-enabled Patient Data Access

By: A Jay Holmgren and Nate C. Apathy

Forthcoming
Article

Regulatory Oversight, Causal Inference, and Safe and Effective Health Care Machine Learning

By: Ariel Dora Stern and W Nicholson Price, II

In recent years, the applications of Machine Learning (ML) in the health care delivery setting have grown to become both abundant and compelling. Regulators have taken notice of these developments and the U.S. Food and Drug Administration (FDA) has been engaging...

Forthcoming
Article

A Review of Bundled Payments in Total Joint Replacement

By: Olivia Manickas-Hill, Kevin J. Bozic and Thomas W. Feeley

The Bundled Payments for Care Improvement (BPCI) initiative, developed by the U.S. Center for Medicare & Medicaid Innovation, aims to reduce health-care expenditures while maintaining or improving patient outcomes. Several published reports evaluating the impact of the...

13 Nov 2019
News

Amy Edmondson: Psychological safety is critically important in medicine

Re: Amy Edmondson

                          When Amy Edmondson, then a PhD candidate at Harvard Business School, set out to study the relationship between error making and teamwork in hospitals, she expected to find that higher performing teams made fewer mistakes.

October 2019
Case

GRIT Fitness

By: Lynda M. Applegate and Olivia Hull

In December 2018, GRIT Fitness was a growing chain of boutique fitness studios offering a variety of workout classes, including weightlifting, high intensity interval training, and cardio dance. With 400 members and three Dallas studios, CEO Brittani Rettig believed...

18 Sep 2019
Working Paper Summaries

Female Inventors and Inventions

by Rembrand Koning, Sampsa Samila, and John-Paul Ferguson

                          Does the gender of inventors make a difference for who benefits from their inventions? Analysis of all U.S. biomedical patents issued between 1976 and 2010 shows that research teams with women were more likely to produce patents addressing women’s health conditions,...

11 Sep 2019
News

Germany May Have the Answer for Reducing Drug Prices

Re: Ariel Dora Stern

                          In Germany, drugmakers must prove that a new medication’s benefits merit a higher price than existing drugs. Ariel Dora Stern asks whether "value-based pricing" should become the standard elsewhere.

10 Sep 2019
News

New Survey Shows U.S. Businesses Taking Steps to Foster Culture Of Health, But Room to Grow

Re: Robert Huckman

                          BOSTON—In a new article published today in The Milbank Quarterly, a multidisciplinary journal of population health and health policy, researchers from Harvard Business School (HBS) and Harvard T.H. Chan School of Public Health, discuss the results of a recently...

Article

Trends and Predictors of Biomedical Research Quality, 1990–2015: A Meta-Research Study

By: Maryaline Catillon

Fall 2019
Article

Endogenous Productivity of Demand-Induced R&D: Evidence from Pharmaceuticals

By: Kyle Myers and Mark Pauly

We examine trends in the productivity of the pharmaceutical sector over the past three decades. Motivated by Ricardo’s insight that productivity and rents are endogenous to demand when inputs are scarce, we examine the industry’s aggregate R&D production function....

Forthcoming
Article

Adaptive Platform Trials: Definition, Design, Conduct and Reporting Considerations

By: Derek C. Angus, Brian M. Alexander, Scott Berry, Meredith Buxton, Roger Lewis, Melissa Paoloni, Steven A. R. Webb, Steven Arnold, Anna Barker, Donald A. Berry, Marc J. M. Bonten, Mary Brophy, Christopher Butler, Timothy F. Cloughesy, Lennie P. G. Derde, Laura J. Esserman, Ryan Ferguson, Louis Fiore, Sarah C. Gaffey, J. Michael Gaziano, Kathy Giusti, Herman Goossens, Stephane Heritier, Bradley Hyman, Michael Krams, Kay Larholt, Lisa M. LaVange, Philip Lavori, Andrew W. Lo, Alexander J. London, Victoria Manax, Colin McArthur, Genevieve O’Neill, Giovanni Parmigiani, Jane Perlmutter, Elizabeth A. Petzold, Craig Ritchie, Kathryn M. Rowan, Christopher W. Seymour, Nathan I. Shapiro, Diane M. Simeone, Bradley Smith, Bradley Spellberg, Ariel Dora Stern, Lorenzo Trippa, Mark Trusheim, Kert Viele, Patrick Y. Wen and Janet Woodcock

Researchers, clinicians, policymakers, and patients are increasingly interested in questions about therapeutic interventions that are difficult or costly to answer with traditional, free-standing, parallel-group randomized controlled trials (RCTs). Examples include...

28 Aug 2019
Working Paper Summaries

Who Drives Digital Innovation? Evidence from the US Medical Device Industry

by Cirrus Foroughi and Ariel Dora Stern

                          Major industries are undergoing a digital transformation, in which key aspects of new product development are migrating to a software-driven context. In the medical device industry, experience matters, as does the geographic clustering of new product development, which...